CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation
Authors:
- Hassen KaredHKHassen Kared
- Andrew D ReddARAndrew D Redd
- Evan M BlochEBEvan M Bloch
- Tania S. BonnyTBTania S. Bonny
- Hermi SumatohHSHermi Sumatoh
- Faris KairiFKFaris Kairi
- Daniel CarbajoDCDaniel Carbajo
- Brian AbelBABrian Abel
- Evan W NewellENEvan W Newell
- Maria P. BettinottiMBMaria P. Bettinotti
- Sarah E. BennerSBSarah E. Benner
- Eshan U. PatelEPEshan U. Patel
Preprint
Abstract
Characterization of the T cell response in individuals who recover from SARS-CoV-2 infection is critical to understanding its contribution to protective immunity. A multiplexed peptide-MHC tetramer approach was used to screen 408 SARS-CoV-2 candidate epitopes for CD8+ T cell recognition in a cross-sectional sample of 30 COVID-19 convalescent individuals. T cells were evaluated using a 28-marker phenotypic panel, and findings were modelled against time from diagnosis, humoral and inflammatory responses. 132 distinct SARS-CoV-2-specific CD8+ T cell epitope responses across six different HLAs were detected, corresponding to 52 unique reactivities. T cell responses were directed against several structural and non-structural virus proteins. Modelling demonstrated a coordinated and dynamic immune response characterized by a decrease in inflammation, increase in neutralizing antibody titer, and differentiation of a specific CD8+ T cell response. Overall, T cells exhibited distinct differentiation into stem-cell and transitional memory states, subsets, which may be key to developing durable protection.Keywords
This publication has 38 references indexed in Scilit:
- DNA vaccine protection against SARS-CoV-2 in rhesus macaquesScience, 2020
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNature, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent IndividualsImmunity, 2020
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed IndividualsCell, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- The coming of age of Langerhans cell histiocytosisNature Immunology, 2019
- Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatmentJournal for ImmunoTherapy of Cancer, 2019
- Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterizationNature Biotechnology, 2013
- High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 IndividualsJournal of Experimental Medicine, 1999